Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

L3 Clinical Genomics > Haematological malignancies > Flashcards

Haematological malignancies Flashcards

1
Q

What are the ways in which tumour suppressor genes and oncogenes can be aberrantly affected in cancer? (6)

A
  • Gain/loss of whole/parts of chromosomes (aneuploidy)
  • Gene deletion/duplication/amplification
  • Genomic rearrangements
  • Epigenetic changes
  • Pathogenic variants
  • Small insertions/deletions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an example of aneuploidy in cancer?

A
  • Trisomy 8 in myeloid leukaemia
  • Results in upregulation of c-MYC proto-oncogene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which gene is amplified in neuroblastoma?

A

n-MYC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an example of loss of large chromosomal regions in cancer?

A
  • Isodicentric chromosome 17 resulting in the loss of 17p and the deletion of TP53
  • del5q
    -del7q
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are examples of genomic rearrangement in cancer? (3)

A
  • Translocation, inversion and insertion resulting in generation of fusion-oncogenes or the silencing of tumour suppressor genes
  • TMPRSS2-ERG in prostate cancer
  • IGH-BCL2 in follicular lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the features of fusion genes? (2)

A
  • They can be specific to a disease and therefore useful diagnostic markers and therapeutic targets
  • Some fusion genes are sufficient to cause disease so abnormalities don’t need to be accumulated to cause the cancer as it can be done in ‘1 hit’ (mostly childhood cancers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is chromothripsis? (3)

A
  • Complex chromosomal rearrangement where major levels of DNA damage result in genome fragmentation
  • Usually causes apoptosis but cancer cells can evade this and end up with a highly complex and abnormal genome
  • Results in more genetic diversity and increased likelihood of competitive clones being produced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are epigenetic changes involved in cancer? (2)

A
  • Methylation of upstream regulatory elements of genes often results in transcriptional suppression
  • Methylation status of tumour suppressor genes and oncogenes can be modified to alter expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are pathogenic variants involved in cancer? (2)

A
  • Point mutations can inactivate tumour suppressor gene function
  • E.g. isodicentric 17 results in loss of one copy of TP53, an inactivating point mutation/frameshift mutation in the other copy would worsen patient prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the prognosis for trisomy 8? (3)

A
  • Intermediate/poor
  • cMYC amplification which is a transcription factor for cell cycle progression and inhibition of anti-proliferation genes
  • Seen in myeloid disease rather than lymphoid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How often is c-MYC constitutively active in cancer?

A

Approx 70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the prognosis for del5q? (2)

A
  • Good is seen as the sole abnormality in MDS as linked to low risk progression to AML
  • Poor if consistent with progression as common marker of therapy-related leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the prognosis for trisomy 7? (3)

A
  • Poor/very poor
  • Highly complex set of candidate genes present on chromosome 7
  • Associated with likely progression to acute leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is an example of epigenetic changes in cancer?

A

Barrett’s oesophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are examples of point mutations seen in AML? (2)

A
  • NPM1
  • FLT3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 3 major strategies for cancer treatment?

A
  • Surgery (removal)
  • Radiotherapy (DNA damage)
  • Chemotherapy (DNA damage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the haematological malignancies? (2)

A
  • Cancers of the blood or blood forming tissues (bone marrow, lymphatic system, peripheral blood)
  • Account for approximately 3% of all cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the most common haematological malignancy seen in children?

A

Acute lymphoblastic leukaemia (ALL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which haematological malignancies are more common in the elderly? (2)

A
  • Acute myeloid leukaemia (AML)
  • Myelodysplastic syndrome (MDS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How rare are haematological malignancies?

A

Approximately 63 new cases per 100 000 individuals per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the 3 major disease classes of haematological malignancy?

A
  • Leukaemia
  • Lymphoma
  • Multiple Myeloma
    (- Myelodysplastic syndromes (MDS) are precancerous disorders that can progress to AML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What makes haematological malignancies clonal?

A

The disease develops from a single cell and the descendants inherit the abnormalities

23
Q

What makes haematological malignancies progressive? (2)

A
  • Progression of the cancer is driven by accumulation of abnormalities in the genome
  • Type, number and distribution of abnormalities can help determine the nature of the disease and be used for monitoring
24
Q

What are markers of disease progression? (2)

A
  • Clonal expansion (proportion of the tissue involved increases)
  • Clonal evolution (abnormal clones accumulate more abnormalities)
25
Q

What is clonal expansion? (2)

A
  • Proliferation of a cancerous clone
  • An indication of disease progression
26
Q

What is clonal evolution? (3)

A
  • When an abnormal clone accumulates further abnormalities
  • Consistent with poor prognosis
  • Likely that the second more complex clone will proliferate more rapidly than the first
27
Q

What is disease load?

A

The proportion of bone marrow which is thought to be cancerous

28
Q

What is remission? (3)

A
  • The point at which the cancer is no longer detected
  • Doesn’t mean the cancer is gone
  • Split into cytogenetic remissions and molecular genetic remissions (molecular being a deeper remission as these techniques are more sensitive)
29
Q

What genomic technologies are used to detect relapses quickly? (2)

A
  • FISH (down to 1% of the bone marrow)
  • Quantitative PCR (1000 times more sensitive than FISH)
30
Q

What are the 2 ways in which relapse can occur?

A
  • Original cancer comes back
  • Cancer with a new genotype emerges
31
Q

How can relapse occur as a new genotype? (2)

A
  • Therapy related disease: therapy to destroy the original cancer causes DNA damage to normal cells which can become new malignant clones
  • The new cancer may have always been present but at undetectable levels but able to proliferate once the major clones have been destroyed by therapy
32
Q

How are haematological malignancies classified? (2)

A
  • Histology
  • Cytology and haematology
33
Q

What is histology? (2)

A
  • Identifying abnormal tissue morphology
  • Density of chromosome staining and nucleus morphology are likely to be altered
34
Q

What is cytology/haematology? (2)

A
  • Reporting on the morphology of stem cells and the derivatives in the bone marrow, lymph nodes and peripheral blood
  • Malignancies change the proportions of cells in the blood which can be characterised by unique morphology
35
Q

How can haematological malignancies affect immature stem cells in the bone marrow? (2)

A
  • Enhancing proliferation
  • Restricting differentiation
36
Q

What are blast cells? (3)

A
  • Immature blood cells
  • Should only be found in the bone marrow but start to appear in peripheral blood as bone marrow becomes more hypercellular
  • The proportion of blast cells in the peripheral blood is important in prognosis
37
Q

What is cytosis?

A

Hypercellularity due to over proliferation of malignant cells

38
Q

What is cytopenia?

A

Too few cells

39
Q

How does cytopenia occur in cancer? (3)

A
  • Organisation of the bone marrow is destroyed in cancer which alters the spaces allowed for each cell type to function normally
  • Filling up of space with abnormal stem cells reduces the space for normal cells to divide resulting in lower number of these lineages (cytopenia) and adds to malfunction of the blood
  • A failure of immature stem cells to fully differentiate results in cytopenia of their terminally differentiated daughters
40
Q

What are the subtypes of lymphoma? (2)

A
  • Hodgkin
  • Non-Hodgkin
41
Q

What is Hodgkin lymphoma? (3)

A
  • Arises in the lymph nodes
  • Characterised by presence of Reed Sternberg Cells
  • Common in young adults
42
Q

Which cell type is affected by lymphoma?

A

B-lymphocytes

43
Q

What is non-Hodgkin lymphoma?

A

Largely re-designated as a leukaemia as they are now thought to arise in the bone marrow not the lymph nodes

44
Q

What is multiple myeloma? (2)

A
  • Characterised by clonal expansion of an abnormal plasma cell which produces an abnormal antibody called an M-protein
  • Over proliferation may also disrupt normal haematopoiesis
45
Q

Which cell type is affected by multiple myeloma?

A

Plasma cells (type of B-lymphocyte)

46
Q
A
47
Q

How is leukaemia classified? (4)

A
  • Myeloid or lymphoid lineage
  • Chronic or acute
48
Q

How is leukaemia determined to be chronic or acute? (2)

A
  • Chronic: blast cells account for less than 20% of nucleated cells in peripheral blood
  • Acute: blast cells account for more than 20%
49
Q

What are the characteristics of chronic myeloid leukaemias? (5)

A
  • Referred to as the myeloproliferative neoplasms
  • 8 types
  • Less than 20% blast cells in PB
  • Affecting myeloid lineage
  • Capable of progression into acute myeloid leukaemia
50
Q

What are myeloproliferative neoplasms?

A

Name for cancers that are chronic myeloid leukaemias

51
Q

What are the characteristics of acute myeloid leukaemias? (2)

A
  • Referred to as “acute myeloid leukaemias and related precursor neoplasms” (AML)
  • Greater than 20% blast cells in PB
52
Q

What are the characteristics of chronic lymphoid leukaemias? (4)

A
  • CLL
  • Affects B-lymphocyte lineage
  • Less than 20% blast cells in PB
  • Typically seen in old age
  • Capable of progression into acute lymphoid leukaemia
53
Q

What are the characteristics of acute lymphoid leukaemias? (3)

A
  • ALL
  • Lymphoid lineage
  • Greater than 20% blast cells in PB

L3 Clinical Genomics (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions